Non Celiac Gluten sensitivity (NCGS) was originally described in the 1980s and recently a “re-discovered” disorder characterized by intestinal and extra-intestinal symptoms related to the ingestion of gluten-containing food, in subjects that are not affected with either celiac disease (CD) or wheat allergy (WA). Although NCGS frequency is still unclear, epidemiological data have been generated that can help establishing the magnitude of the problem. Clinical studies further defined the identity of NCGS and its implications in human disease. An overlap between the irritable bowel syndrome (IBS) and NCGS has been detected, requiring even more stringent diagnostic criteria. Several studies suggested a relationship between NCGS and neuropsychiatric disorders, particularly autism and schizophrenia. The first case reports of NCGS in children have been described. Lack of biomarkers is still a major limitation of clinical studies, making it difficult to differentiate NCGS from other gluten related disorders. Recent studies raised the possibility that, beside gluten, wheat amylase-trypsin inhibitors and low-fermentable, poorly-absorbed, short-chain carbohydrates can contribute to symptoms (at least those related to IBS) experienced by NCGS patients. In this paper we report the major advances and current trends on NCGS.
Sanders, D.S.; Aziz, I. Non celiac wheat sensitivity: Separating the wheat from the chaff. Am. J. Gastroenterol. 2012, 107, 1908–1912, doi:10.1038/ajg.2012.344.
Ludvigsson, J.F.; Leffler, D.A.; Bai, J.C.; Biagi, F.; Fasano, A.; Green, P.H.; Hadjivassiliou, M.; Kaukinen, K.; Kelly, C.P.; Leonard, J.N.; et al. The Oslo definitions for coeliac disease and related terms. Gut 2013, 62, 43–52, doi:10.1136/gutjnl-2011-301346.
Koletzko, S.; Niggemann, B.; Arato, A.; Dias, J.A.; Heuschkel, R.; Husby, S.; Mearin, M.L.; Papadopoulou, A.; Ruemmele, F.M.; Staiano, A.; et al. European Society of Pediatric Gastroenterology, Hepatology, and Nutrition. Diagnostic approach and management of cow’s-milk protein allergy in infants and children: ESPGHAN GI Committee practical guidelines. J. Pediatr. Gastroenterol. Nutr. 2012, 55, 221–229, doi:10.1097/MPG.0b013e31825c9482.
Tanpowpong, P.; Broder-Fingert, S.; Katz, A.J.; Camargo, C.A., Jr. Predictors of gluten avoidance and implementation of a gluten-free diet in children and adolescents without confirmed celiac disease. J. Pediatr. 2012, 161, 471–475, doi:10.1016/j.jpeds.2012.02.049.
Digiacomo, D.V.; Tennyson, C.A.; Green, P.H.; Demmer, R.T. Prevalence of gluten-free diet adherence among individuals without celiac disease in the USA: Results from the Continuous National Health and Nutrition Examination Survey 2009–2010. Scand. J. Gastroenterol. 2013, 48, 921–925.
Krosgaard, L.R.; Engsbro, A.L.; Bytzer, P. The epidemiology of irritable bowel syndrome in Denmark. A population-based survey in adults < 50 years of age. Scand. J. Gastroenterol. 2013, 48, 523–299, doi:10.3109/00365521.2013.775328.
Brottveit, M.; Vandvik, P.O.; Wojniusz, S.; L?vik, A.; Lundin, K.E.; Boye, B. Absence of somatization in non-coeliac gluten sensitivity. Scand. J. Gastroenterol. 2012, 47, 770–777.
Vazquez-Roque, M.I.; Camilleri, M.; Smirk, T.; Murray, J.A.; Marietta, E.; O’Neill, J.; Carlson, P.; Lamsam, J. A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: Effects on bowel frequency and intestinal function. Gastroenterology 2013, 144, 903–911, doi:10.1053/j.gastro.2013.01.049.
Marcason, W. What is the current status of research concerning use of a gluten-free, casein-free diet for children diagnosed with autism? J. Am. Diet. Assoc. 2009, 109, 572, doi:10.1016/j.jada.2009.01.013.
De Magistris, L.; Familiari, V.; Pascotto, A.; Sapone, A.; Frolli, A.; Iardino, P.; Carteni, M.; de Rosa, M.; Francavilla, R.; Riegler, G.; et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J. Pediatr. Gastroenterol. Nutr. 2010, 51, 418–424, doi:10.1097/MPG.0b013e3181dcc4a5.
Robertson, M.A.; Sigalet, D.L.; Holst, J.J.; Meddings, J.B.; Wood, J.; Sharkey, K.A. Intestinal permeability and glucagon-like peptide-2 in children with autism: A controlled pilot study. J. Autism Dev. Disord. 2008, 38, 1066–1071, doi:10.1007/s10803-007-0482-1.
Lau, N.M.; Green, P.H.; Taylor, A.K.; Hellberg, D.; Ajamian, M.; Tan, C.Z.; Kosofsky, B.E.; Higgins, J.J.; Rajadhyaksha, A.M.; Alaedini, A. Markers of celiac disease and gluten sensitivity in children with autism. PLoS One 2013, 8, e66155, doi:10.1371/journal.pone.0066155.
Whiteley, P.; Haracopos, D.; Knivsberg, A.M.; Reichelt, K.L.; Parlar, S.; Jacobsen, J.; Seim, A.; Pedersen, L.; Schondel, M.; Shattock, P. The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders. Nutr. Neurosci. 2010, 13, 87–100, doi:10.1179/147683010X12611460763922.
Storms, L.H.; Clopton, J.M.; Wright, C. Effects of gluten in schizophrenics. Arch. Gen. Psychiatry 1982, 39, 323–327, doi:10.1001/archpsyc.1982.04290030055010.
Cascella, N.G.; Kryszak, D.; Bhatti, B.; Gregory, P.; Kelly, D.L.; Mc Evoy, J.P.; Fasano, A.; Eaton, W.W. Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population. Schizophr. Bull. 2011, 37, 94–100, doi:10.1093/schbul/sbp055.